JAAHA Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hillers, K. R.
Right arrow Articles by LaRue, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hillers, K. R.
Right arrow Articles by LaRue, S. M.
Journal of the American Animal Hospital Association 43:187-192 (2007)
© 2007 American Animal Hospital Association

Retrospective Study

Effects of Palliative Radiation Therapy on Nonsplenic Hemangiosarcoma in Dogs

Kim R. Hillers, DVM, Susan E. Lana, DVM, MS, Diplomate ACVIM (Oncology), Chana R. Fuller, CVT and Susan M. LaRue, DVM, PhD, Diplomate ACVS, Diplomate ACVR (Radiation Therapy)

From the Animal Cancer Center (Lana, Fuller, LaRue), the Department of Clinical Sciences (Lana), the Department of Environmental Health and Radiological Sciences (Fuller, LaRue), the James L. Voss Veterinary Teaching Hospital, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, 300 West Drake Road, Fort Collins, Colorado 80523-1620.

Medical records for 20 dogs with histologically confirmed nonsplenic hemangiosarcomas treated with palliative radiation therapy were reviewed to evaluate factors influencing tumor response and survival time. The Kaplan-Meier median survival time of dogs that received palliative radiation therapy was 95 days (range 6 to 500 days). Subjective reduction in tumor size was seen in 14 dogs, with four complete responses. Tumor location was a significant univariate prognostic factor for survival, and dogs with retroperitoneal masses had longer survival times.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Animal Hospital Association.